Expand IMUX Menu
IMUX MENU

IMUX Latest Press Releases

-- September 2, 2026 --

Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 PRNewswire 6:31 AM

-- September 1, 2026 --

Immunic Appoints Chitrang Dav as Chief Data and Digital Officer PRNewswire 6:30 AM

-- August 11, 2026 --

Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update PRNewswire 6:30 AM

-- August 10, 2026 --

Immunic Appoints Elena Ridloff to Board of Directors PRNewswire 4:05 PM

-- July 9, 2026 --

Immunic to Participate in Investor Conferences in July PRNewswire 6:30 AM

-- June 10, 2026 --

Immunic to Participate in Investor, Industry and Scientific Conferences in June PRNewswire 6:30 AM

-- May 28, 2026 --

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis PRNewswire 6:30 AM

-- May 27, 2026 --

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer PRNewswire 6:30 AM

-- May 19, 2026 --

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors PRNewswire 6:30 AM

-- May 13, 2026 --

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update PRNewswire 6:30 AM

-- April 30, 2026 --

Immunic to Participate in Investor and Medical Conferences in May PRNewswire 6:30 AM

-- April 28, 2026 --

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer PRNewswire 6:30 AM
Market Data Delayed 15 Minutes